Delivery Order SPE2DB24D1205-SPE2DB25FCVYY
Award Date
4/18/25
Potential Completion Date
5/9/25
Potential Value
$4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ingrezza 40 mg capsules, a medication used to treat a neurological condition. The contract has a total ceiling value of $3,676.12 and a performance period ending on May 23, 2025. It is a firm-fixed-price contract, meaning the price of the deliverables is predetermined. The contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the medication Ingrezza 80 mg capsules. The contract has a ceiling value of $3,893.15 and a period of performance through June 6, 2024. It is a firm-fixed-price contract, with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $7,352.24 delivery order contract is for the supply of Ingrezza 40 mg capsules, a medication used to treat neurological conditions. The contract has a firm fixed price and an ultimate completion date of May 28, 2025. This award is not set-aside and represents open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $3,676.12, is for the delivery of the pharmaceutical product Ingrezza 40 mg capsules. The contract has a firm fixed price and an ultimate completion date of May 7, 2025. This contract is not set aside and represents an open competition award. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,083.10, is for the delivery of Ingrezza 80 mg capsules over the period ending April 8, 2025. The contract is a firm-fixed-price arrangement and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,893.15, is for the delivery of Ingrezza 80 mg capsules. The contract has an ultimate completion date of July 25, 2024 and was awarded on July 3, 2024. The contract is not designated with any set-aside requirements, indicating open competition. AmerisourceBergen holds a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,119.55 firm-fixed-price contract is for the delivery of Ingrezza 40 mg capsules, a specialty medication, to support military healthcare programs. The contract has a completion date of June 21, 2023 and is not set aside for any specific business type. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,077,699 units of the prescription medication Ingrezza 60 mg capsules. The contract has a ceiling value of $4,049.61 and a period of performance through May 20, 2025. The contract is not set aside for any specific business category. AmerisourceBergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,027.70, is a delivery order for the supply of the prescription medication Ingrezza 80 mg capsules. The contract is a firm fixed-price, non-set-aside award with a performance period through May 1, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Ingrezza 40 mg capsules. The contract, valued at $6,239.10, is a firm fixed-price delivery order with an ultimate completion date of April 14, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) held by the parent company, Cencora, Inc., doing business as AmerisourceBergen, with the DLA Troop Support Medical...